nodes	percent_of_prediction	percent_of_DWPC	metapath
Eprosartan—ABCC2—Sulfasalazine—rheumatoid arthritis	0.179	0.276	CbGbCtD
Eprosartan—ABCC2—Cyclosporine—rheumatoid arthritis	0.136	0.209	CbGbCtD
Eprosartan—CYP2C9—Leflunomide—rheumatoid arthritis	0.0972	0.15	CbGbCtD
Eprosartan—ABCC2—Dexamethasone—rheumatoid arthritis	0.0893	0.138	CbGbCtD
Eprosartan—ABCC2—Methotrexate—rheumatoid arthritis	0.0717	0.111	CbGbCtD
Eprosartan—CYP2C9—Cyclosporine—rheumatoid arthritis	0.0455	0.0703	CbGbCtD
Eprosartan—CYP2C9—Dexamethasone—rheumatoid arthritis	0.03	0.0463	CbGbCtD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CXCL13—rheumatoid arthritis	0.000607	0.00776	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—HLA-DQB1—rheumatoid arthritis	0.000596	0.00762	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—IL1A—rheumatoid arthritis	0.000566	0.00724	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—CD40LG—rheumatoid arthritis	0.000563	0.00719	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—IL10—rheumatoid arthritis	0.000563	0.00719	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—IL4—rheumatoid arthritis	0.000547	0.007	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CX3CR1—rheumatoid arthritis	0.000541	0.00692	CbGpPWpGaD
Eprosartan—AGTR1—Peptide GPCRs—CCR5—rheumatoid arthritis	0.000536	0.00686	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—HLA-B—rheumatoid arthritis	0.000535	0.00684	CbGpPWpGaD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—MMP2—rheumatoid arthritis	0.000534	0.00683	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CXCL6—rheumatoid arthritis	0.000526	0.00673	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—FASLG—rheumatoid arthritis	0.000523	0.00669	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—FAS—rheumatoid arthritis	0.000504	0.00645	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—C5—rheumatoid arthritis	0.000503	0.00643	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CCL21—rheumatoid arthritis	0.000502	0.00642	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—IL2RA—rheumatoid arthritis	0.000502	0.00641	CbGpPWpGaD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—NOS3—rheumatoid arthritis	0.0005	0.00639	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—C3—rheumatoid arthritis	0.000497	0.00636	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—HLA-A—rheumatoid arthritis	0.000496	0.00634	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CCR6—rheumatoid arthritis	0.000473	0.00605	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—HLA-DRB1—rheumatoid arthritis	0.000453	0.00579	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CXCL2—rheumatoid arthritis	0.000433	0.00553	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CCL3—rheumatoid arthritis	0.000433	0.00553	CbGpPWpGaD
Eprosartan—AGTR1—G alpha (q) signalling events—SAA1—rheumatoid arthritis	0.000429	0.00548	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—CX3CR1—rheumatoid arthritis	0.000424	0.00542	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—SAA1—rheumatoid arthritis	0.000423	0.00541	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—CD80—rheumatoid arthritis	0.000419	0.00535	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL13—rheumatoid arthritis	0.000407	0.00521	CbGpPWpGaD
Eprosartan—CYP2C9—Arachidonic acid metabolism—ALOX5—rheumatoid arthritis	0.000401	0.00513	CbGpPWpGaD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—NFKB1—rheumatoid arthritis	0.000397	0.00508	CbGpPWpGaD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—MAPK8—rheumatoid arthritis	0.00039	0.00499	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—SAA1—rheumatoid arthritis	0.000383	0.0049	CbGpPWpGaD
Eprosartan—AGTR1—G alpha (q) signalling events—BDKRB2—rheumatoid arthritis	0.000373	0.00476	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR6—rheumatoid arthritis	0.00037	0.00474	CbGpPWpGaD
Eprosartan—AGTR1—G alpha (q) signalling events—ADRBK1—rheumatoid arthritis	0.000368	0.00471	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CXCL12—rheumatoid arthritis	0.000368	0.0047	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—BDKRB2—rheumatoid arthritis	0.000368	0.0047	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CX3CR1—rheumatoid arthritis	0.000363	0.00464	CbGpPWpGaD
Eprosartan—AGTR1—G alpha (q) signalling events—RASGRP1—rheumatoid arthritis	0.000348	0.00444	CbGpPWpGaD
Eprosartan—AGTR1—G alpha (q) signalling events—PRKCQ—rheumatoid arthritis	0.00034	0.00435	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—C5—rheumatoid arthritis	0.000338	0.00432	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—BDKRB2—rheumatoid arthritis	0.000333	0.00426	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—IFNG—rheumatoid arthritis	0.000331	0.00423	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—ADRBK1—rheumatoid arthritis	0.00033	0.00421	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CXCL10—rheumatoid arthritis	0.000325	0.00416	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR6—rheumatoid arthritis	0.000317	0.00406	CbGpPWpGaD
Eprosartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—rheumatoid arthritis	0.000311	0.00398	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—rheumatoid arthritis	0.000311	0.00397	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CXCL13—rheumatoid arthritis	0.00031	0.00397	CbGpPWpGaD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—rheumatoid arthritis	0.000309	0.00395	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—CXCL8—rheumatoid arthritis	0.000308	0.00393	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PRKCQ—rheumatoid arthritis	0.000304	0.00389	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CXCL6—rheumatoid arthritis	0.000297	0.0038	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—IL1B—rheumatoid arthritis	0.000295	0.00377	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—IL2—rheumatoid arthritis	0.000294	0.00376	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL3—rheumatoid arthritis	0.00029	0.00371	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL2—rheumatoid arthritis	0.00029	0.00371	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—BDKRB2—rheumatoid arthritis	0.000288	0.00368	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—LCN2—rheumatoid arthritis	0.000285	0.00365	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—SAA1—rheumatoid arthritis	0.000284	0.00363	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CCL21—rheumatoid arthritis	0.000284	0.00363	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CCL5—rheumatoid arthritis	0.00028	0.00358	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CX3CR1—rheumatoid arthritis	0.000276	0.00353	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CXCL6—rheumatoid arthritis	0.00027	0.00345	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—rheumatoid arthritis	0.000269	0.00343	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CCL21—rheumatoid arthritis	0.000258	0.00329	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—C5—rheumatoid arthritis	0.000257	0.00329	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CCR5—rheumatoid arthritis	0.000252	0.00322	CbGpPWpGaD
Eprosartan—Angioedema—Betamethasone—rheumatoid arthritis	0.000252	0.000919	CcSEcCtD
Eprosartan—Anorexia—Hydrocortisone—rheumatoid arthritis	0.000251	0.000916	CcSEcCtD
Eprosartan—AGTR1—Allograft Rejection—VEGFA—rheumatoid arthritis	0.00025	0.00319	CbGpPWpGaD
Eprosartan—Conjunctivitis—Methotrexate—rheumatoid arthritis	0.000249	0.00091	CcSEcCtD
Eprosartan—Malaise—Dexamethasone—rheumatoid arthritis	0.000248	0.000907	CcSEcCtD
Eprosartan—Malaise—Betamethasone—rheumatoid arthritis	0.000248	0.000907	CcSEcCtD
Eprosartan—Vertigo—Dexamethasone—rheumatoid arthritis	0.000247	0.000904	CcSEcCtD
Eprosartan—Vertigo—Betamethasone—rheumatoid arthritis	0.000247	0.000904	CcSEcCtD
Eprosartan—Syncope—Betamethasone—rheumatoid arthritis	0.000247	0.000902	CcSEcCtD
Eprosartan—Syncope—Dexamethasone—rheumatoid arthritis	0.000247	0.000902	CcSEcCtD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL12—rheumatoid arthritis	0.000247	0.00316	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—BDKRB2—rheumatoid arthritis	0.000247	0.00316	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—C3—rheumatoid arthritis	0.000246	0.00315	CbGpPWpGaD
Eprosartan—Hypotension—Hydrocortisone—rheumatoid arthritis	0.000246	0.000898	CcSEcCtD
Eprosartan—Haematuria—Methotrexate—rheumatoid arthritis	0.000244	0.000893	CcSEcCtD
Eprosartan—Feeling abnormal—Cyclosporine—rheumatoid arthritis	0.000244	0.000891	CcSEcCtD
Eprosartan—Vomiting—Leflunomide—rheumatoid arthritis	0.000244	0.000891	CcSEcCtD
Eprosartan—Shock—Triamcinolone—rheumatoid arthritis	0.000244	0.00089	CcSEcCtD
Eprosartan—Insomnia—Prednisolone—rheumatoid arthritis	0.000244	0.00089	CcSEcCtD
Eprosartan—Shock—Methylprednisolone—rheumatoid arthritis	0.000243	0.000888	CcSEcCtD
Eprosartan—Gastrointestinal pain—Cyclosporine—rheumatoid arthritis	0.000242	0.000884	CcSEcCtD
Eprosartan—Loss of consciousness—Betamethasone—rheumatoid arthritis	0.000242	0.000884	CcSEcCtD
Eprosartan—Loss of consciousness—Dexamethasone—rheumatoid arthritis	0.000242	0.000884	CcSEcCtD
Eprosartan—Epistaxis—Methotrexate—rheumatoid arthritis	0.000242	0.000883	CcSEcCtD
Eprosartan—Paraesthesia—Prednisolone—rheumatoid arthritis	0.000242	0.000883	CcSEcCtD
Eprosartan—Rash—Leflunomide—rheumatoid arthritis	0.000242	0.000883	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—CCR6—rheumatoid arthritis	0.000242	0.00309	CbGpPWpGaD
Eprosartan—Tachycardia—Triamcinolone—rheumatoid arthritis	0.000242	0.000883	CcSEcCtD
Eprosartan—Dermatitis—Leflunomide—rheumatoid arthritis	0.000242	0.000882	CcSEcCtD
Eprosartan—Nausea—Azathioprine—rheumatoid arthritis	0.000241	0.000881	CcSEcCtD
Eprosartan—Tachycardia—Methylprednisolone—rheumatoid arthritis	0.000241	0.000881	CcSEcCtD
Eprosartan—Headache—Leflunomide—rheumatoid arthritis	0.00024	0.000877	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Hydrocortisone—rheumatoid arthritis	0.00024	0.000875	CcSEcCtD
Eprosartan—Hyperhidrosis—Triamcinolone—rheumatoid arthritis	0.000239	0.000875	CcSEcCtD
Eprosartan—Hyperhidrosis—Methylprednisolone—rheumatoid arthritis	0.000239	0.000873	CcSEcCtD
Eprosartan—Insomnia—Hydrocortisone—rheumatoid arthritis	0.000238	0.000869	CcSEcCtD
Eprosartan—Paraesthesia—Hydrocortisone—rheumatoid arthritis	0.000236	0.000863	CcSEcCtD
Eprosartan—Urticaria—Cyclosporine—rheumatoid arthritis	0.000235	0.000859	CcSEcCtD
Eprosartan—Myalgia—Betamethasone—rheumatoid arthritis	0.000234	0.000856	CcSEcCtD
Eprosartan—Myalgia—Dexamethasone—rheumatoid arthritis	0.000234	0.000856	CcSEcCtD
Eprosartan—Body temperature increased—Cyclosporine—rheumatoid arthritis	0.000234	0.000855	CcSEcCtD
Eprosartan—Abdominal pain—Cyclosporine—rheumatoid arthritis	0.000234	0.000855	CcSEcCtD
Eprosartan—Anxiety—Betamethasone—rheumatoid arthritis	0.000234	0.000853	CcSEcCtD
Eprosartan—Anxiety—Dexamethasone—rheumatoid arthritis	0.000234	0.000853	CcSEcCtD
Eprosartan—Discomfort—Dexamethasone—rheumatoid arthritis	0.000232	0.000846	CcSEcCtD
Eprosartan—Discomfort—Betamethasone—rheumatoid arthritis	0.000232	0.000846	CcSEcCtD
Eprosartan—Dyspepsia—Hydrocortisone—rheumatoid arthritis	0.000231	0.000846	CcSEcCtD
Eprosartan—Hypotension—Methylprednisolone—rheumatoid arthritis	0.000231	0.000843	CcSEcCtD
Eprosartan—Pain—Prednisolone—rheumatoid arthritis	0.00023	0.000841	CcSEcCtD
Eprosartan—AGTR1—Allograft Rejection—TGFB1—rheumatoid arthritis	0.000229	0.00293	CbGpPWpGaD
Eprosartan—Decreased appetite—Hydrocortisone—rheumatoid arthritis	0.000229	0.000835	CcSEcCtD
Eprosartan—Pharyngitis—Methotrexate—rheumatoid arthritis	0.000228	0.000835	CcSEcCtD
Eprosartan—Nausea—Leflunomide—rheumatoid arthritis	0.000228	0.000832	CcSEcCtD
Eprosartan—Fatigue—Hydrocortisone—rheumatoid arthritis	0.000227	0.000828	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	0.000226	0.000824	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—PDE2A—rheumatoid arthritis	0.000225	0.00288	CbGpPWpGaD
Eprosartan—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	0.000225	0.000822	CcSEcCtD
Eprosartan—Pain—Hydrocortisone—rheumatoid arthritis	0.000225	0.000822	CcSEcCtD
Eprosartan—Insomnia—Triamcinolone—rheumatoid arthritis	0.000224	0.000818	CcSEcCtD
Eprosartan—Insomnia—Methylprednisolone—rheumatoid arthritis	0.000223	0.000816	CcSEcCtD
Eprosartan—Ill-defined disorder—Prednisone—rheumatoid arthritis	0.000222	0.000813	CcSEcCtD
Eprosartan—Paraesthesia—Triamcinolone—rheumatoid arthritis	0.000222	0.000812	CcSEcCtD
Eprosartan—Feeling abnormal—Prednisolone—rheumatoid arthritis	0.000222	0.000811	CcSEcCtD
Eprosartan—Paraesthesia—Methylprednisolone—rheumatoid arthritis	0.000222	0.00081	CcSEcCtD
Eprosartan—Visual impairment—Methotrexate—rheumatoid arthritis	0.000222	0.00081	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—CCL3—rheumatoid arthritis	0.000221	0.00283	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CXCL2—rheumatoid arthritis	0.000221	0.00283	CbGpPWpGaD
Eprosartan—Shock—Dexamethasone—rheumatoid arthritis	0.000221	0.000808	CcSEcCtD
Eprosartan—Shock—Betamethasone—rheumatoid arthritis	0.000221	0.000808	CcSEcCtD
Eprosartan—Dyspnoea—Triamcinolone—rheumatoid arthritis	0.000221	0.000807	CcSEcCtD
Eprosartan—Thrombocytopenia—Betamethasone—rheumatoid arthritis	0.00022	0.000804	CcSEcCtD
Eprosartan—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	0.00022	0.000804	CcSEcCtD
Eprosartan—Tachycardia—Dexamethasone—rheumatoid arthritis	0.000219	0.000801	CcSEcCtD
Eprosartan—Tachycardia—Betamethasone—rheumatoid arthritis	0.000219	0.000801	CcSEcCtD
Eprosartan—Angioedema—Prednisone—rheumatoid arthritis	0.000219	0.0008	CcSEcCtD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL10—rheumatoid arthritis	0.000218	0.00279	CbGpPWpGaD
Eprosartan—Hypersensitivity—Cyclosporine—rheumatoid arthritis	0.000218	0.000796	CcSEcCtD
Eprosartan—Dyspepsia—Triamcinolone—rheumatoid arthritis	0.000218	0.000796	CcSEcCtD
Eprosartan—Dyspepsia—Methylprednisolone—rheumatoid arthritis	0.000217	0.000795	CcSEcCtD
Eprosartan—Hyperhidrosis—Betamethasone—rheumatoid arthritis	0.000217	0.000793	CcSEcCtD
Eprosartan—Hyperhidrosis—Dexamethasone—rheumatoid arthritis	0.000217	0.000793	CcSEcCtD
Eprosartan—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	0.000217	0.000792	CcSEcCtD
Eprosartan—Malaise—Prednisone—rheumatoid arthritis	0.000216	0.00079	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—SAA1—rheumatoid arthritis	0.000216	0.00276	CbGpPWpGaD
Eprosartan—Vertigo—Prednisone—rheumatoid arthritis	0.000215	0.000787	CcSEcCtD
Eprosartan—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	0.000215	0.000786	CcSEcCtD
Eprosartan—Syncope—Prednisone—rheumatoid arthritis	0.000215	0.000785	CcSEcCtD
Eprosartan—Tinnitus—Methotrexate—rheumatoid arthritis	0.000215	0.000784	CcSEcCtD
Eprosartan—AGTR1—Allograft Rejection—TNF—rheumatoid arthritis	0.000214	0.00274	CbGpPWpGaD
Eprosartan—Anorexia—Betamethasone—rheumatoid arthritis	0.000214	0.000782	CcSEcCtD
Eprosartan—Anorexia—Dexamethasone—rheumatoid arthritis	0.000214	0.000782	CcSEcCtD
Eprosartan—Urticaria—Prednisolone—rheumatoid arthritis	0.000214	0.000781	CcSEcCtD
Eprosartan—Fatigue—Triamcinolone—rheumatoid arthritis	0.000213	0.00078	CcSEcCtD
Eprosartan—Fatigue—Methylprednisolone—rheumatoid arthritis	0.000213	0.000778	CcSEcCtD
Eprosartan—Asthenia—Cyclosporine—rheumatoid arthritis	0.000212	0.000776	CcSEcCtD
Eprosartan—Pain—Triamcinolone—rheumatoid arthritis	0.000212	0.000774	CcSEcCtD
Eprosartan—Loss of consciousness—Prednisone—rheumatoid arthritis	0.000211	0.00077	CcSEcCtD
Eprosartan—Hypotension—Betamethasone—rheumatoid arthritis	0.00021	0.000767	CcSEcCtD
Eprosartan—Hypotension—Dexamethasone—rheumatoid arthritis	0.00021	0.000767	CcSEcCtD
Eprosartan—Pruritus—Cyclosporine—rheumatoid arthritis	0.000209	0.000765	CcSEcCtD
Eprosartan—Urticaria—Hydrocortisone—rheumatoid arthritis	0.000209	0.000763	CcSEcCtD
Eprosartan—Abdominal pain—Hydrocortisone—rheumatoid arthritis	0.000208	0.000759	CcSEcCtD
Eprosartan—Body temperature increased—Hydrocortisone—rheumatoid arthritis	0.000208	0.000759	CcSEcCtD
Eprosartan—ABCC2—NRF2 pathway—AGER—rheumatoid arthritis	0.000207	0.00265	CbGpPWpGaD
Eprosartan—Chills—Methotrexate—rheumatoid arthritis	0.000207	0.000754	CcSEcCtD
Eprosartan—AGTR1—Signaling by GPCR—PDE2A—rheumatoid arthritis	0.000205	0.00262	CbGpPWpGaD
Eprosartan—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	0.000205	0.000748	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	0.000205	0.000748	CcSEcCtD
Eprosartan—Arthralgia—Prednisone—rheumatoid arthritis	0.000204	0.000746	CcSEcCtD
Eprosartan—Myalgia—Prednisone—rheumatoid arthritis	0.000204	0.000746	CcSEcCtD
Eprosartan—Feeling abnormal—Triamcinolone—rheumatoid arthritis	0.000204	0.000745	CcSEcCtD
Eprosartan—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	0.000204	0.000744	CcSEcCtD
Eprosartan—Anxiety—Prednisone—rheumatoid arthritis	0.000203	0.000743	CcSEcCtD
Eprosartan—Insomnia—Dexamethasone—rheumatoid arthritis	0.000203	0.000742	CcSEcCtD
Eprosartan—Insomnia—Betamethasone—rheumatoid arthritis	0.000203	0.000742	CcSEcCtD
Eprosartan—Diarrhoea—Cyclosporine—rheumatoid arthritis	0.000202	0.00074	CcSEcCtD
Eprosartan—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	0.000202	0.000738	CcSEcCtD
Eprosartan—Paraesthesia—Dexamethasone—rheumatoid arthritis	0.000202	0.000737	CcSEcCtD
Eprosartan—Paraesthesia—Betamethasone—rheumatoid arthritis	0.000202	0.000737	CcSEcCtD
Eprosartan—Discomfort—Prednisone—rheumatoid arthritis	0.000202	0.000737	CcSEcCtD
Eprosartan—Hypersensitivity—Prednisolone—rheumatoid arthritis	0.000198	0.000725	CcSEcCtD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC22A4—rheumatoid arthritis	0.000198	0.00253	CbGpPWpGaD
Eprosartan—Dyspepsia—Dexamethasone—rheumatoid arthritis	0.000198	0.000723	CcSEcCtD
Eprosartan—Dyspepsia—Betamethasone—rheumatoid arthritis	0.000198	0.000723	CcSEcCtD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR5—rheumatoid arthritis	0.000197	0.00252	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—POMC—rheumatoid arthritis	0.000197	0.00252	CbGpPWpGaD
Eprosartan—Urticaria—Triamcinolone—rheumatoid arthritis	0.000197	0.000719	CcSEcCtD
Eprosartan—Urticaria—Methylprednisolone—rheumatoid arthritis	0.000196	0.000717	CcSEcCtD
Eprosartan—Body temperature increased—Triamcinolone—rheumatoid arthritis	0.000196	0.000715	CcSEcCtD
Eprosartan—Dizziness—Cyclosporine—rheumatoid arthritis	0.000196	0.000715	CcSEcCtD
Eprosartan—Abdominal pain—Methylprednisolone—rheumatoid arthritis	0.000195	0.000714	CcSEcCtD
Eprosartan—Decreased appetite—Dexamethasone—rheumatoid arthritis	0.000195	0.000714	CcSEcCtD
Eprosartan—Decreased appetite—Betamethasone—rheumatoid arthritis	0.000195	0.000714	CcSEcCtD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6ST—rheumatoid arthritis	0.000195	0.0025	CbGpPWpGaD
Eprosartan—Back pain—Methotrexate—rheumatoid arthritis	0.000194	0.000708	CcSEcCtD
Eprosartan—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	0.000194	0.000708	CcSEcCtD
Eprosartan—Fatigue—Dexamethasone—rheumatoid arthritis	0.000194	0.000708	CcSEcCtD
Eprosartan—Fatigue—Betamethasone—rheumatoid arthritis	0.000194	0.000708	CcSEcCtD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CCL2—rheumatoid arthritis	0.000193	0.00247	CbGpPWpGaD
Eprosartan—Shock—Prednisone—rheumatoid arthritis	0.000192	0.000703	CcSEcCtD
Eprosartan—Pain—Betamethasone—rheumatoid arthritis	0.000192	0.000702	CcSEcCtD
Eprosartan—Pain—Dexamethasone—rheumatoid arthritis	0.000192	0.000702	CcSEcCtD
Eprosartan—Tachycardia—Prednisone—rheumatoid arthritis	0.000191	0.000698	CcSEcCtD
Eprosartan—Hyperhidrosis—Prednisone—rheumatoid arthritis	0.000189	0.000691	CcSEcCtD
Eprosartan—Asthenia—Hydrocortisone—rheumatoid arthritis	0.000189	0.000689	CcSEcCtD
Eprosartan—Vomiting—Cyclosporine—rheumatoid arthritis	0.000188	0.000687	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—CXCL12—rheumatoid arthritis	0.000188	0.0024	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—BDKRB2—rheumatoid arthritis	0.000188	0.0024	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL5—rheumatoid arthritis	0.000188	0.0024	CbGpPWpGaD
Eprosartan—Rash—Cyclosporine—rheumatoid arthritis	0.000187	0.000682	CcSEcCtD
Eprosartan—Anorexia—Prednisone—rheumatoid arthritis	0.000186	0.000681	CcSEcCtD
Eprosartan—Dermatitis—Cyclosporine—rheumatoid arthritis	0.000186	0.000681	CcSEcCtD
Eprosartan—Pruritus—Hydrocortisone—rheumatoid arthritis	0.000186	0.00068	CcSEcCtD
Eprosartan—Ill-defined disorder—Methotrexate—rheumatoid arthritis	0.000186	0.000679	CcSEcCtD
Eprosartan—Headache—Cyclosporine—rheumatoid arthritis	0.000185	0.000677	CcSEcCtD
Eprosartan—Feeling abnormal—Dexamethasone—rheumatoid arthritis	0.000185	0.000676	CcSEcCtD
Eprosartan—Feeling abnormal—Betamethasone—rheumatoid arthritis	0.000185	0.000676	CcSEcCtD
Eprosartan—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	0.000184	0.000671	CcSEcCtD
Eprosartan—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	0.000184	0.000671	CcSEcCtD
Eprosartan—Hypersensitivity—Triamcinolone—rheumatoid arthritis	0.000182	0.000666	CcSEcCtD
Eprosartan—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	0.000182	0.000665	CcSEcCtD
Eprosartan—Malaise—Methotrexate—rheumatoid arthritis	0.000181	0.00066	CcSEcCtD
Eprosartan—Vertigo—Methotrexate—rheumatoid arthritis	0.00018	0.000658	CcSEcCtD
Eprosartan—Diarrhoea—Hydrocortisone—rheumatoid arthritis	0.00018	0.000657	CcSEcCtD
Eprosartan—Urticaria—Betamethasone—rheumatoid arthritis	0.000178	0.000652	CcSEcCtD
Eprosartan—Urticaria—Dexamethasone—rheumatoid arthritis	0.000178	0.000652	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	0.000178	0.000651	CcSEcCtD
Eprosartan—Dizziness—Prednisolone—rheumatoid arthritis	0.000178	0.00065	CcSEcCtD
Eprosartan—Asthenia—Triamcinolone—rheumatoid arthritis	0.000178	0.000649	CcSEcCtD
Eprosartan—Body temperature increased—Dexamethasone—rheumatoid arthritis	0.000178	0.000649	CcSEcCtD
Eprosartan—Body temperature increased—Betamethasone—rheumatoid arthritis	0.000178	0.000649	CcSEcCtD
Eprosartan—Abdominal pain—Betamethasone—rheumatoid arthritis	0.000178	0.000649	CcSEcCtD
Eprosartan—Abdominal pain—Dexamethasone—rheumatoid arthritis	0.000178	0.000649	CcSEcCtD
Eprosartan—Asthenia—Methylprednisolone—rheumatoid arthritis	0.000177	0.000648	CcSEcCtD
Eprosartan—Insomnia—Prednisone—rheumatoid arthritis	0.000177	0.000647	CcSEcCtD
Eprosartan—Nausea—Cyclosporine—rheumatoid arthritis	0.000176	0.000642	CcSEcCtD
Eprosartan—Paraesthesia—Prednisone—rheumatoid arthritis	0.000176	0.000642	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—CXCL13—rheumatoid arthritis	0.000175	0.00224	CbGpPWpGaD
Eprosartan—Pruritus—Triamcinolone—rheumatoid arthritis	0.000175	0.00064	CcSEcCtD
Eprosartan—Cough—Methotrexate—rheumatoid arthritis	0.000175	0.000639	CcSEcCtD
Eprosartan—Pruritus—Methylprednisolone—rheumatoid arthritis	0.000175	0.000639	CcSEcCtD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—rheumatoid arthritis	0.000174	0.00223	CbGpPWpGaD
Eprosartan—Dizziness—Hydrocortisone—rheumatoid arthritis	0.000174	0.000635	CcSEcCtD
Eprosartan—Dyspepsia—Prednisone—rheumatoid arthritis	0.000172	0.000629	CcSEcCtD
Eprosartan—Arthralgia—Methotrexate—rheumatoid arthritis	0.000171	0.000623	CcSEcCtD
Eprosartan—Myalgia—Methotrexate—rheumatoid arthritis	0.000171	0.000623	CcSEcCtD
Eprosartan—Chest pain—Methotrexate—rheumatoid arthritis	0.000171	0.000623	CcSEcCtD
Eprosartan—Decreased appetite—Prednisone—rheumatoid arthritis	0.00017	0.000621	CcSEcCtD
Eprosartan—Rash—Prednisolone—rheumatoid arthritis	0.00017	0.00062	CcSEcCtD
Eprosartan—Dermatitis—Prednisolone—rheumatoid arthritis	0.00017	0.00062	CcSEcCtD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR5—rheumatoid arthritis	0.000169	0.00216	CbGpPWpGaD
Eprosartan—Diarrhoea—Methylprednisolone—rheumatoid arthritis	0.000169	0.000618	CcSEcCtD
Eprosartan—Fatigue—Prednisone—rheumatoid arthritis	0.000169	0.000616	CcSEcCtD
Eprosartan—Headache—Prednisolone—rheumatoid arthritis	0.000169	0.000616	CcSEcCtD
Eprosartan—Discomfort—Methotrexate—rheumatoid arthritis	0.000169	0.000616	CcSEcCtD
Eprosartan—Constipation—Prednisone—rheumatoid arthritis	0.000167	0.000611	CcSEcCtD
Eprosartan—Vomiting—Hydrocortisone—rheumatoid arthritis	0.000167	0.000611	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—CXCL10—rheumatoid arthritis	0.000166	0.00212	CbGpPWpGaD
Eprosartan—Rash—Hydrocortisone—rheumatoid arthritis	0.000166	0.000606	CcSEcCtD
Eprosartan—Dermatitis—Hydrocortisone—rheumatoid arthritis	0.000166	0.000605	CcSEcCtD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—C3—rheumatoid arthritis	0.000165	0.00211	CbGpPWpGaD
Eprosartan—Headache—Hydrocortisone—rheumatoid arthritis	0.000165	0.000602	CcSEcCtD
Eprosartan—Dizziness—Triamcinolone—rheumatoid arthritis	0.000164	0.000598	CcSEcCtD
Eprosartan—Dizziness—Methylprednisolone—rheumatoid arthritis	0.000163	0.000597	CcSEcCtD
Eprosartan—ABCC2—Transmembrane transport of small molecules—MED1—rheumatoid arthritis	0.000161	0.00206	CbGpPWpGaD
Eprosartan—Feeling abnormal—Prednisone—rheumatoid arthritis	0.000161	0.000589	CcSEcCtD
Eprosartan—Asthenia—Betamethasone—rheumatoid arthritis	0.000161	0.000589	CcSEcCtD
Eprosartan—Asthenia—Dexamethasone—rheumatoid arthritis	0.000161	0.000589	CcSEcCtD
Eprosartan—Thrombocytopenia—Methotrexate—rheumatoid arthritis	0.00016	0.000585	CcSEcCtD
Eprosartan—Gastrointestinal pain—Prednisone—rheumatoid arthritis	0.00016	0.000585	CcSEcCtD
Eprosartan—Nausea—Prednisolone—rheumatoid arthritis	0.00016	0.000584	CcSEcCtD
Eprosartan—AGTR1—Signaling Pathways—CXCL6—rheumatoid arthritis	0.00016	0.00204	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CXCL13—rheumatoid arthritis	0.000159	0.00204	CbGpPWpGaD
Eprosartan—Pruritus—Betamethasone—rheumatoid arthritis	0.000159	0.000581	CcSEcCtD
Eprosartan—Pruritus—Dexamethasone—rheumatoid arthritis	0.000159	0.000581	CcSEcCtD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—rheumatoid arthritis	0.000159	0.00203	CbGpPWpGaD
Eprosartan—Hyperhidrosis—Methotrexate—rheumatoid arthritis	0.000158	0.000578	CcSEcCtD
Eprosartan—Vomiting—Triamcinolone—rheumatoid arthritis	0.000157	0.000575	CcSEcCtD
Eprosartan—Vomiting—Methylprednisolone—rheumatoid arthritis	0.000157	0.000574	CcSEcCtD
Eprosartan—Nausea—Hydrocortisone—rheumatoid arthritis	0.000156	0.000571	CcSEcCtD
Eprosartan—Rash—Triamcinolone—rheumatoid arthritis	0.000156	0.00057	CcSEcCtD
Eprosartan—Dermatitis—Triamcinolone—rheumatoid arthritis	0.000156	0.00057	CcSEcCtD
Eprosartan—Anorexia—Methotrexate—rheumatoid arthritis	0.000156	0.000569	CcSEcCtD
Eprosartan—Rash—Methylprednisolone—rheumatoid arthritis	0.000156	0.000569	CcSEcCtD
Eprosartan—Dermatitis—Methylprednisolone—rheumatoid arthritis	0.000156	0.000569	CcSEcCtD
Eprosartan—Urticaria—Prednisone—rheumatoid arthritis	0.000155	0.000568	CcSEcCtD
Eprosartan—Headache—Triamcinolone—rheumatoid arthritis	0.000155	0.000567	CcSEcCtD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—FADS2—rheumatoid arthritis	0.000155	0.00198	CbGpPWpGaD
Eprosartan—Headache—Methylprednisolone—rheumatoid arthritis	0.000155	0.000565	CcSEcCtD
Eprosartan—Body temperature increased—Prednisone—rheumatoid arthritis	0.000155	0.000565	CcSEcCtD
Eprosartan—Abdominal pain—Prednisone—rheumatoid arthritis	0.000155	0.000565	CcSEcCtD
Eprosartan—Diarrhoea—Dexamethasone—rheumatoid arthritis	0.000154	0.000562	CcSEcCtD
Eprosartan—Diarrhoea—Betamethasone—rheumatoid arthritis	0.000154	0.000562	CcSEcCtD
Eprosartan—Hypotension—Methotrexate—rheumatoid arthritis	0.000153	0.000558	CcSEcCtD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CXCL8—rheumatoid arthritis	0.000152	0.00195	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—SYVN1—rheumatoid arthritis	0.000152	0.00195	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCL21—rheumatoid arthritis	0.000152	0.00195	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—IL2RB—rheumatoid arthritis	0.00015	0.00192	CbGpPWpGaD
Eprosartan—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	0.000149	0.000544	CcSEcCtD
Eprosartan—Dizziness—Dexamethasone—rheumatoid arthritis	0.000149	0.000543	CcSEcCtD
Eprosartan—Dizziness—Betamethasone—rheumatoid arthritis	0.000149	0.000543	CcSEcCtD
Eprosartan—Insomnia—Methotrexate—rheumatoid arthritis	0.000148	0.00054	CcSEcCtD
Eprosartan—Nausea—Triamcinolone—rheumatoid arthritis	0.000147	0.000537	CcSEcCtD
Eprosartan—Paraesthesia—Methotrexate—rheumatoid arthritis	0.000147	0.000536	CcSEcCtD
Eprosartan—Nausea—Methylprednisolone—rheumatoid arthritis	0.000147	0.000536	CcSEcCtD
Eprosartan—AGTR1—Signaling Pathways—TAGAP—rheumatoid arthritis	0.000146	0.00187	CbGpPWpGaD
Eprosartan—Dyspnoea—Methotrexate—rheumatoid arthritis	0.000146	0.000533	CcSEcCtD
Eprosartan—Somnolence—Methotrexate—rheumatoid arthritis	0.000145	0.000531	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—C5—rheumatoid arthritis	0.000145	0.00186	CbGpPWpGaD
Eprosartan—Hypersensitivity—Prednisone—rheumatoid arthritis	0.000144	0.000527	CcSEcCtD
Eprosartan—Dyspepsia—Methotrexate—rheumatoid arthritis	0.000144	0.000526	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—CCL5—rheumatoid arthritis	0.000143	0.00183	CbGpPWpGaD
Eprosartan—Vomiting—Betamethasone—rheumatoid arthritis	0.000143	0.000522	CcSEcCtD
Eprosartan—Vomiting—Dexamethasone—rheumatoid arthritis	0.000143	0.000522	CcSEcCtD
Eprosartan—Decreased appetite—Methotrexate—rheumatoid arthritis	0.000142	0.000519	CcSEcCtD
Eprosartan—AGTR1—Signaling by GPCR—CX3CR1—rheumatoid arthritis	0.000142	0.00181	CbGpPWpGaD
Eprosartan—Rash—Betamethasone—rheumatoid arthritis	0.000142	0.000518	CcSEcCtD
Eprosartan—Rash—Dexamethasone—rheumatoid arthritis	0.000142	0.000518	CcSEcCtD
Eprosartan—Dermatitis—Betamethasone—rheumatoid arthritis	0.000142	0.000517	CcSEcCtD
Eprosartan—Dermatitis—Dexamethasone—rheumatoid arthritis	0.000142	0.000517	CcSEcCtD
Eprosartan—Fatigue—Methotrexate—rheumatoid arthritis	0.000141	0.000515	CcSEcCtD
Eprosartan—Headache—Dexamethasone—rheumatoid arthritis	0.000141	0.000514	CcSEcCtD
Eprosartan—Headache—Betamethasone—rheumatoid arthritis	0.000141	0.000514	CcSEcCtD
Eprosartan—Asthenia—Prednisone—rheumatoid arthritis	0.00014	0.000513	CcSEcCtD
Eprosartan—Pain—Methotrexate—rheumatoid arthritis	0.00014	0.000511	CcSEcCtD
Eprosartan—Pruritus—Prednisone—rheumatoid arthritis	0.000138	0.000506	CcSEcCtD
Eprosartan—AGTR1—Signaling by GPCR—IL2RB—rheumatoid arthritis	0.000137	0.00175	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CCR6—rheumatoid arthritis	0.000137	0.00175	CbGpPWpGaD
Eprosartan—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—rheumatoid arthritis	0.000136	0.00174	CbGpPWpGaD
Eprosartan—Feeling abnormal—Methotrexate—rheumatoid arthritis	0.000135	0.000492	CcSEcCtD
Eprosartan—Diarrhoea—Prednisone—rheumatoid arthritis	0.000134	0.000489	CcSEcCtD
Eprosartan—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	0.000134	0.000489	CcSEcCtD
Eprosartan—Nausea—Dexamethasone—rheumatoid arthritis	0.000133	0.000488	CcSEcCtD
Eprosartan—Nausea—Betamethasone—rheumatoid arthritis	0.000133	0.000488	CcSEcCtD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—POMC—rheumatoid arthritis	0.000132	0.00169	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—C5—rheumatoid arthritis	0.000132	0.00169	CbGpPWpGaD
Eprosartan—Urticaria—Methotrexate—rheumatoid arthritis	0.00013	0.000475	CcSEcCtD
Eprosartan—Dizziness—Prednisone—rheumatoid arthritis	0.000129	0.000473	CcSEcCtD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL2—rheumatoid arthritis	0.000129	0.00165	CbGpPWpGaD
Eprosartan—Abdominal pain—Methotrexate—rheumatoid arthritis	0.000129	0.000472	CcSEcCtD
Eprosartan—Body temperature increased—Methotrexate—rheumatoid arthritis	0.000129	0.000472	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—CCR5—rheumatoid arthritis	0.000129	0.00165	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—C3—rheumatoid arthritis	0.000126	0.00161	CbGpPWpGaD
Eprosartan—CYP2C9—Arachidonic acid metabolism—PTGS2—rheumatoid arthritis	0.000125	0.0016	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CXCL2—rheumatoid arthritis	0.000125	0.0016	CbGpPWpGaD
Eprosartan—Vomiting—Prednisone—rheumatoid arthritis	0.000124	0.000454	CcSEcCtD
Eprosartan—AGTR1—Signaling by GPCR—CCR6—rheumatoid arthritis	0.000124	0.00159	CbGpPWpGaD
Eprosartan—Rash—Prednisone—rheumatoid arthritis	0.000123	0.000451	CcSEcCtD
Eprosartan—Dermatitis—Prednisone—rheumatoid arthritis	0.000123	0.00045	CcSEcCtD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC11A1—rheumatoid arthritis	0.000123	0.00157	CbGpPWpGaD
Eprosartan—Headache—Prednisone—rheumatoid arthritis	0.000123	0.000448	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—SAA1—rheumatoid arthritis	0.000122	0.00156	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PDE2A—rheumatoid arthritis	0.000121	0.00155	CbGpPWpGaD
Eprosartan—Hypersensitivity—Methotrexate—rheumatoid arthritis	0.00012	0.00044	CcSEcCtD
Eprosartan—Asthenia—Methotrexate—rheumatoid arthritis	0.000117	0.000429	CcSEcCtD
Eprosartan—Nausea—Prednisone—rheumatoid arthritis	0.000116	0.000425	CcSEcCtD
Eprosartan—Pruritus—Methotrexate—rheumatoid arthritis	0.000116	0.000423	CcSEcCtD
Eprosartan—AGTR1—Signaling Pathways—PLB1—rheumatoid arthritis	0.000115	0.00147	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CCL3—rheumatoid arthritis	0.000113	0.00145	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CXCL2—rheumatoid arthritis	0.000113	0.00145	CbGpPWpGaD
Eprosartan—Diarrhoea—Methotrexate—rheumatoid arthritis	0.000112	0.000409	CcSEcCtD
Eprosartan—AGTR1—Signaling by GPCR—SAA1—rheumatoid arthritis	0.000111	0.00142	CbGpPWpGaD
Eprosartan—CYP2C9—Phase 1 - Functionalization of compounds—POMC—rheumatoid arthritis	0.00011	0.00141	CbGpPWpGaD
Eprosartan—Dizziness—Methotrexate—rheumatoid arthritis	0.000108	0.000395	CcSEcCtD
Eprosartan—AGTR1—Signaling Pathways—RBPJ—rheumatoid arthritis	0.000106	0.00136	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—BDKRB2—rheumatoid arthritis	0.000106	0.00136	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CXCL12—rheumatoid arthritis	0.000106	0.00136	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—ADRBK1—rheumatoid arthritis	0.000105	0.00134	CbGpPWpGaD
Eprosartan—Vomiting—Methotrexate—rheumatoid arthritis	0.000104	0.00038	CcSEcCtD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PLD4—rheumatoid arthritis	0.000103	0.00132	CbGpPWpGaD
Eprosartan—Rash—Methotrexate—rheumatoid arthritis	0.000103	0.000377	CcSEcCtD
Eprosartan—Dermatitis—Methotrexate—rheumatoid arthritis	0.000103	0.000376	CcSEcCtD
Eprosartan—Headache—Methotrexate—rheumatoid arthritis	0.000102	0.000374	CcSEcCtD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—rheumatoid arthritis	0.000102	0.00131	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—POMC—rheumatoid arthritis	0.000101	0.00129	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—RASGRP1—rheumatoid arthritis	9.91e-05	0.00127	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CCL2—rheumatoid arthritis	9.85e-05	0.00126	CbGpPWpGaD
Eprosartan—Nausea—Methotrexate—rheumatoid arthritis	9.71e-05	0.000355	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—PRKCQ—rheumatoid arthritis	9.69e-05	0.00124	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CXCL12—rheumatoid arthritis	9.64e-05	0.00123	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—BDKRB2—rheumatoid arthritis	9.64e-05	0.00123	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—ADRBK1—rheumatoid arthritis	9.54e-05	0.00122	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CXCL13—rheumatoid arthritis	9.4e-05	0.0012	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CXCL10—rheumatoid arthritis	9.39e-05	0.0012	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—rheumatoid arthritis	9.14e-05	0.00117	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—GC—rheumatoid arthritis	9.14e-05	0.00117	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—RASGRP1—rheumatoid arthritis	9e-05	0.00115	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PRKCQ—rheumatoid arthritis	8.8e-05	0.00113	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—TGFB1—rheumatoid arthritis	8.76e-05	0.00112	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CXCL10—rheumatoid arthritis	8.52e-05	0.00109	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—rheumatoid arthritis	8.49e-05	0.00109	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TLE3—rheumatoid arthritis	8.47e-05	0.00108	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IRAK1—rheumatoid arthritis	8.47e-05	0.00108	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CX3CR1—rheumatoid arthritis	8.38e-05	0.00107	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CCL5—rheumatoid arthritis	8.08e-05	0.00103	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IL2RB—rheumatoid arthritis	8.07e-05	0.00103	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CSF2—rheumatoid arthritis	7.96e-05	0.00102	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—C5—rheumatoid arthritis	7.79e-05	0.000996	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CXCL8—rheumatoid arthritis	7.79e-05	0.000996	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—MMP3—rheumatoid arthritis	7.77e-05	0.000994	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—rheumatoid arthritis	7.76e-05	0.000992	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NFATC1—rheumatoid arthritis	7.67e-05	0.00098	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—MED1—rheumatoid arthritis	7.45e-05	0.000952	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CCL5—rheumatoid arthritis	7.34e-05	0.000938	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCR6—rheumatoid arthritis	7.33e-05	0.000937	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CCR5—rheumatoid arthritis	7.28e-05	0.000931	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CSF2—rheumatoid arthritis	7.23e-05	0.000924	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—IL2RA—rheumatoid arthritis	7.17e-05	0.000917	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NCF2—rheumatoid arthritis	7.13e-05	0.000911	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—C3—rheumatoid arthritis	7.11e-05	0.00091	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TRAF6—rheumatoid arthritis	6.95e-05	0.000888	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—SH2B3—rheumatoid arthritis	6.95e-05	0.000888	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—FADS2—rheumatoid arthritis	6.9e-05	0.000883	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—GZMB—rheumatoid arthritis	6.9e-05	0.000882	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCL3—rheumatoid arthritis	6.7e-05	0.000857	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CXCL2—rheumatoid arthritis	6.7e-05	0.000857	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CCR5—rheumatoid arthritis	6.61e-05	0.000845	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—SAA1—rheumatoid arthritis	6.55e-05	0.000838	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—IL2RA—rheumatoid arthritis	6.51e-05	0.000833	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—C3—rheumatoid arthritis	6.46e-05	0.000826	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NCF1—rheumatoid arthritis	6.42e-05	0.00082	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CD28—rheumatoid arthritis	6.17e-05	0.000789	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—POMC—rheumatoid arthritis	5.85e-05	0.000748	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—UBE2D1—rheumatoid arthritis	5.81e-05	0.000743	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	5.74e-05	0.000734	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—BDKRB2—rheumatoid arthritis	5.7e-05	0.000728	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CXCL12—rheumatoid arthritis	5.7e-05	0.000728	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—POMC—rheumatoid arthritis	5.69e-05	0.000727	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—IL6ST—rheumatoid arthritis	5.65e-05	0.000722	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ADRBK1—rheumatoid arthritis	5.63e-05	0.00072	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—RASGRP1—rheumatoid arthritis	5.31e-05	0.000679	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—SYK—rheumatoid arthritis	5.3e-05	0.000677	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PRKCQ—rheumatoid arthritis	5.2e-05	0.000665	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—POMC—rheumatoid arthritis	5.17e-05	0.000661	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—STAT1—rheumatoid arthritis	5.11e-05	0.000653	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CCL2—rheumatoid arthritis	5.05e-05	0.000646	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—IL6R—rheumatoid arthritis	5.04e-05	0.000644	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CXCL10—rheumatoid arthritis	5.04e-05	0.000644	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PLD4—rheumatoid arthritis	4.61e-05	0.000589	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MMP3—rheumatoid arthritis	4.59e-05	0.000587	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—TYK2—rheumatoid arthritis	4.59e-05	0.000587	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ACAN—rheumatoid arthritis	4.45e-05	0.000569	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	4.43e-05	0.000567	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PTK2—rheumatoid arthritis	4.42e-05	0.000565	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CXCL8—rheumatoid arthritis	4.4e-05	0.000563	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCL5—rheumatoid arthritis	4.33e-05	0.000554	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CSF2—rheumatoid arthritis	4.27e-05	0.000546	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—IL2—rheumatoid arthritis	4.21e-05	0.000538	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SLC25A12—rheumatoid arthritis	4.18e-05	0.000535	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PTGES—rheumatoid arthritis	4.07e-05	0.00052	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GC—rheumatoid arthritis	4.07e-05	0.00052	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—SPP1—rheumatoid arthritis	4.01e-05	0.000513	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CXCL8—rheumatoid arthritis	4e-05	0.000511	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCR5—rheumatoid arthritis	3.91e-05	0.000499	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IL2RA—rheumatoid arthritis	3.85e-05	0.000492	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—IL2—rheumatoid arthritis	3.82e-05	0.000488	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—C3—rheumatoid arthritis	3.82e-05	0.000488	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PLB1—rheumatoid arthritis	3.78e-05	0.000484	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—LEP—rheumatoid arthritis	3.55e-05	0.000454	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—FN1—rheumatoid arthritis	3.35e-05	0.000428	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IL6ST—rheumatoid arthritis	3.34e-05	0.000427	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—MED1—rheumatoid arthritis	3.32e-05	0.000424	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CD80—rheumatoid arthritis	3.21e-05	0.000411	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—B3GNT2—rheumatoid arthritis	3.08e-05	0.000394	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ACP5—rheumatoid arthritis	3.08e-05	0.000394	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—POMC—rheumatoid arthritis	3.05e-05	0.00039	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCL2—rheumatoid arthritis	2.99e-05	0.000382	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IL6R—rheumatoid arthritis	2.98e-05	0.000381	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—BGN—rheumatoid arthritis	2.78e-05	0.000355	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TYK2—rheumatoid arthritis	2.71e-05	0.000347	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NOS3—rheumatoid arthritis	2.66e-05	0.00034	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ALOX5—rheumatoid arthritis	2.56e-05	0.000327	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CXCL8—rheumatoid arthritis	2.36e-05	0.000302	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IL2—rheumatoid arthritis	2.26e-05	0.000288	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	2.25e-05	0.000287	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—IL6—rheumatoid arthritis	2.24e-05	0.000287	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MMP9—rheumatoid arthritis	2.14e-05	0.000273	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NFKB1—rheumatoid arthritis	2.11e-05	0.00027	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ENO1—rheumatoid arthritis	2.08e-05	0.000266	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MAPK8—rheumatoid arthritis	2.08e-05	0.000266	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	2.05e-05	0.000262	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—VEGFA—rheumatoid arthritis	1.92e-05	0.000245	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	1.79e-05	0.000229	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TGFB1—rheumatoid arthritis	1.76e-05	0.000225	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CAT—rheumatoid arthritis	1.5e-05	0.000192	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TP53—rheumatoid arthritis	1.45e-05	0.000185	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IL6—rheumatoid arthritis	1.33e-05	0.00017	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—MTHFR—rheumatoid arthritis	1.25e-05	0.00016	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—POMC—rheumatoid arthritis	1e-05	0.000128	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ALB—rheumatoid arthritis	9.12e-06	0.000117	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—NOS3—rheumatoid arthritis	8.73e-06	0.000112	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PTGS2—rheumatoid arthritis	7.98e-06	0.000102	CbGpPWpGaD
